Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Verily
Biotech
Takeda welcomes new oncology chief from CRISPR—Chutes & Ladders
Ex-CRISPR Tx CMO lands at Takeda. Lexeo adds Pfizer rare disease leader as development chief. Merck & Co. leader to join Cartography.
Max Bayer
,
Gabrielle Masson
Feb 9, 2024 9:30am
Verily launches new biomedical data management platform
Oct 5, 2023 12:00pm
Letter of the day for Alphabet's Verily is O for OneOncology
Aug 17, 2023 4:30am
Verily narrows focus, cutting device work and laying off staff
Jan 12, 2023 3:15pm
Verily's Onduo slashes blood sugar in Type 2 diabetes patients
Nov 7, 2022 10:30am
Verily to build data-powered registry of IBD patients
Oct 25, 2022 10:00am